# Terazosin

NDC: 27241-288
Generic name: Terazosin
Labeler / Manufacturer: Ajanta Pharma USA Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20250512

FDA application: ANDA219482

## Active ingredients

- TERAZOSIN HYDROCHLORIDE: 1 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"27241-288"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=27241-288
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bed99c2a-4266-4a2c-bb0f-7643fdafff78